Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Dipak Panigrahy, Molly M. Gilligan, Sui Huang, et al.
Cancer and Metastasis Reviews (2020) Vol. 39, Iss. 2, pp. 337-340
Open Access | Times Cited: 209

Showing 26-50 of 209 citing articles:

C-reactive protein-to-lymphocyte ratio is a reliable marker in patients with COVID-19 infection: the CLEAR COVID study
Muhammed Emin Demirkol, Satılmış Bilgin, Gizem Kahveci, et al.
Cirugía y Cirujanos (English Edition) (2024) Vol. 90, Iss. 5
Open Access | Times Cited: 10
Expert consensus report on lipid mediators: Role in resolution of inflammation and muscle preservation
Charles N. Serhan, Magnus Bäck, Valerio Chiurchiù, et al.
The FASEB Journal (2024) Vol. 38, Iss. 10
Open Access | Times Cited: 9
Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression
Anna Fishbein, Weicang Wang, Haixia Yang, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 35, pp. 21576-21587
Open Access | Times Cited: 65
Association of TNF-α G-308 a Promoter Polymorphism with the Course and Outcome of COVID-19 Patients
Ahmed Saleh, Ahmed Sultan, Mohamed A. Elashry, et al.
Immunological Investigations (2020) Vol. 51, Iss. 3, pp. 546-557
Open Access | Times Cited: 61
Novel SARS-CoV-2 outbreak and COVID19 disease; a systemic review on the global pandemic
Abdulmohsen H Alrohaimi, Faisal Alotaibi
Genes & Diseases (2020) Vol. 7, Iss. 4, pp. 491-501
Open Access | Times Cited: 59
SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing
Alistair V.W. Nunn, Geoffrey W. Guy, Wolfgang Brysch, et al.
Immunity & Ageing (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 57
Is the heart rate variability monitoring using the analgesia nociception index a predictor of illness severity and mortality in critically ill patients with COVID-19? A pilot study
Cristian Aragón‐Benedí, Pablo Oliver-Forniés, Felice Galluccio, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0249128-e0249128
Open Access | Times Cited: 48
Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm
Chang Hoon Lee
Archives of Pharmacal Research (2021) Vol. 44, Iss. 1, pp. 84-98
Open Access | Times Cited: 45
Role of arachidonic cascade in COVID-19 infection: A review
Md. Abdur Rahman Ripon, Dipty Rani Bhowmik, Mohammad Tohidul Amin, et al.
Prostaglandins & Other Lipid Mediators (2021) Vol. 154, pp. 106539-106539
Open Access | Times Cited: 44
Proteasome Inhibitors and Their Pharmacokinetics, Pharmacodynamics, and Metabolism
Jinhai Wang, Ying Fang, Rong Fan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11595-11595
Open Access | Times Cited: 41
Potential of Omega 3 Supplementation for Coronavirus Disease 2019 (COVID-19): A Scoping Review
Nanda Nursyifa Fadiyah, Ginna Megawati, Dimas Erlangga Luftimas
International Journal of General Medicine (2022) Vol. Volume 15, pp. 3915-3922
Open Access | Times Cited: 32
Specialized pro-resolving mediators as modulators of immune responses
Walker Julliard, Y.P.A. Myo, Apostolos Perelas, et al.
Seminars in Immunology (2022) Vol. 59, pp. 101605-101605
Open Access | Times Cited: 32
The role of antigen-presenting cells in the pathogenesis of COVID-19
Rana Farzi, Parisa Shiri Aghbash, Narges Eslami, et al.
Pathology - Research and Practice (2022) Vol. 233, pp. 153848-153848
Open Access | Times Cited: 28
The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection
Claudio Gallo, Sirio Fiorino, Giovanni Posabella, et al.
Prostaglandins & Other Lipid Mediators (2022) Vol. 159, pp. 106619-106619
Open Access | Times Cited: 27
Single nucleotide polymorphisms located in TNFA, IL1RN, IL6R, and IL6 genes are associated with COVID‐19 risk and severity in an Iranian population
Mohsen Rokni, Mohammad Sarhadi, Milad Heidari Nia, et al.
Cell Biology International (2022) Vol. 46, Iss. 7, pp. 1109-1127
Open Access | Times Cited: 27
Regulation of inflammation in cancer by dietary eicosanoids
Haixia Yang, Eva Rothenberger, Tong Zhao, et al.
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108455-108455
Closed Access | Times Cited: 17
Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections
Fernanda S. Rasquel-Oliveira, Matheus Deroco Veloso da Silva, Geovana Martelossi-Cebinelli, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5032-5032
Open Access | Times Cited: 16
Nanosystems for modulation of immune responses in periodontal therapy: a mini-review
Anirudh B. Acharya, Usha Hegde, Swetha Acharya
Frontiers in Dental Medicine (2025) Vol. 5
Open Access
Elucidating Potential of Dietary PUFAs (Ω-3) In Tackling Cytokine Storm Syndrome by Attenuation of Pro-Inflammatory Cytokines
Faris F. Aba Alkhayl
Indian Journal of Pharmaceutical Education and Research (2025) Vol. 59, Iss. 1, pp. 1-12
Closed Access
A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes
Colin Funk, Ali Ardakani
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 47
Bioactive Lipids in COVID-19-Further Evidence
Undurti N. Das
Archives of Medical Research (2020) Vol. 52, Iss. 1, pp. 107-120
Open Access | Times Cited: 47
Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019
Leo F. Buckley, George F. Wohlford, Clara Ting, et al.
Critical Care Explorations (2020) Vol. 2, Iss. 8, pp. e0178-e0178
Open Access | Times Cited: 42
Interleukin-1in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective
Amirhossein Mardi, Sepideh Meidaninikjeh, Sepideh Nikfarjam, et al.
Viral Immunology (2021) Vol. 34, Iss. 10, pp. 679-688
Closed Access | Times Cited: 38
Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review
Argus Sun, Tyler Hoffman, Bao Q. Luu, et al.
Bio-Design and Manufacturing (2021) Vol. 4, Iss. 4, pp. 757-775
Open Access | Times Cited: 37
Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development
Ailin Yang, Yanjun Wu, Ganggang Yu, et al.
Respiratory Research (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 36

Scroll to top